Seres Therapeutics's total assets for Q1 2025 were $164.18M, an increase of 17.43% from the previous quarter. MCRB total liabilities were $113.72M for the fiscal quarter, a -9.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.